Intimation of Schedule of the Investors/Analysts Meet to be held on August 14, 2026

Ref: Akums/Exchange/2026-27/43 August 10, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Intimation of Schedule of the Investors/Analysts Meet Respected Sir/Ma’am, This is to inform you that pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals Limited (“the Company”) will participate in the below scheduled investor/analysts meet: S. No. Particulars of Meet Date & Time of Type of Meet Location / Mode Meeting of Meeting 1 Emkay Confluence 14th August, 2026 Group Meet Grand Hyatt 2026 – India: Full starts at 09:00 AM (Mumbai)/ Physical Throttle Ahead (IST) Further, no unpublished price sensitive information pertaining to the Company will be shared during the meet with Analysts/Investors. Please note that the above may subject to change due to exigencies on the part of Investors/analysts or the Company. A copy of this disclosure is being updated on website of the Company at www.akums.in This is for your information and records. For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer